BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Moodys
US Department of Justice
Baxter
Chubb
Deloitte
AstraZeneca
Citi
Johnson and Johnson
Healthtrust

Generated: January 21, 2018

DrugPatentWatch Database Preview

Anda Repository Company Profile

« Back to Dashboard

What is the competitive landscape for ANDA REPOSITORY, and what generic and branded alternatives to ANDA REPOSITORY drugs are available?

ANDA REPOSITORY has thirty approved drugs.



Summary for Anda Repository
US Patents:0
Tradenames:14
Ingredients:14
NDAs:30

Drugs and US Patents for Anda Repository

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Anda Repository HYDRALAZINE HYDROCHLORIDE hydralazine hydrochloride TABLET;ORAL 089359-001 Jul 25, 1986 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Anda Repository PRIMIDONE primidone TABLET;ORAL 040626-001 Sep 29, 2005 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Anda Repository CHLORDIAZEPOXIDE AND AMITRIPTYLINE HYDROCHLORIDE amitriptyline hydrochloride; chlordiazepoxide TABLET;ORAL 070766-001 Dec 10, 1986 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Anda Repository HYDRALAZINE HYDROCHLORIDE hydralazine hydrochloride TABLET;ORAL 088729-001 Apr 11, 1985 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Anda Repository BISOPROLOL FUMARATE bisoprolol fumarate TABLET;ORAL 075474-001 Oct 25, 2002 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Anda Repository PRIMIDONE primidone TABLET;ORAL 040626-002 Sep 29, 2005 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Anda Repository OXAZEPAM oxazepam CAPSULE;ORAL 071026-002 Aug 10, 1987 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Anda Repository HALOPERIDOL haloperidol TABLET;ORAL 071173-001 Jan 7, 1988 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Anda Repository HALOPERIDOL haloperidol TABLET;ORAL 071157-001 Jan 2, 1987 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Anda Repository HYDRALAZINE HYDROCHLORIDE hydralazine hydrochloride TABLET;ORAL 089258-001 May 5, 1986 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Queensland Health
McKinsey
Teva
Cantor Fitzgerald
Chinese Patent Office
Novartis
Moodys
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot